Bruce Meiklejohn

Bruce Meiklejohn is currently the Vice President of CMC at Omeros. Bruce was a Consultant in Biotechnology, at Meiklejohn Consulting LLC. Bruce was a Senior Research Fellow in Regulatory Affairs Chemistry, Manufacturing and Control Biotechnology at Lilly Research Laboratories, Indianapolis, IN. He was with Lilly 27 years predominantly in the area biotechnology after receiving his Ph.D. in Analytical Chemistry from Colorado State University. He supported the biopharmaceutical portfolio, including clinical trials and market registrations. He helped develop global regulatory strategy for biotech products, devices, drugs / device combination products, line extensions and compendia monographs in collaboration with other regulatory, development, and project personnel. He provided regulatory CMC strategy and guidance to teams on CMC issues. He also lead the Biopharmaceutical Division for eight years and conducted GMP audits.